OTC Markets OTCPK - Delayed Quote USD

Raia Drogasil S.A. (RADLY)

Compare
5.0000 +0.6300 (+14.42%)
At close: November 20 at 3:09 PM EST
Loading Chart for RADLY
DELL
  • Previous Close 4.3700
  • Open 4.9900
  • Bid 4.7000 x 40000
  • Ask 5.0000 x 40000
  • Day's Range 4.7600 - 5.0100
  • 52 Week Range 3.8700 - 14.0000
  • Volume 19,593
  • Avg. Volume 27,341
  • Market Cap (intraday) 8.576B
  • Beta (5Y Monthly) 0.31
  • PE Ratio (TTM) 45.45
  • EPS (TTM) 0.1100
  • Earnings Date Nov 5, 2024
  • Forward Dividend & Yield 0.05 (0.98%)
  • Ex-Dividend Date Oct 15, 2024
  • 1y Target Est --

Raia Drogasil S.A. engages in the retail sale of medicines, perfumery, personal care and beauty products, cosmetics, dermocosmetics, and specialty medicines in Brazil. It sells its products through stores, telesales, and call centers in the states of São Paulo, Tocantins, and Pernambuco. The company was founded in 1905 and is headquartered in São Paulo, Brazil.

rdsaude.com.br

62,402

Full Time Employees

December 31

Fiscal Year Ends

Recent News: RADLY

View More

Performance Overview: RADLY

Trailing total returns as of 11/20/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

RADLY
29.81%
IBOVESPA
4.46%

1-Year Return

RADLY
1.77%
IBOVESPA
2.51%

3-Year Return

RADLY
25.71%
IBOVESPA
24.42%

5-Year Return

RADLY
2.41%
IBOVESPA
21.38%

Compare To: RADLY

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: RADLY

View More

Valuation Measures

Annual
As of 11/20/2024
  • Market Cap

    7.66B

  • Enterprise Value

    8.90B

  • Trailing P/E

    43.48

  • Forward P/E

    32.47

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.28

  • Price/Book (mrq)

    7.86

  • Enterprise Value/Revenue

    1.36

  • Enterprise Value/EBITDA

    16.30

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.94%

  • Return on Assets (ttm)

    7.12%

  • Return on Equity (ttm)

    18.81%

  • Revenue (ttm)

    37.7B

  • Net Income Avi to Common (ttm)

    1.11B

  • Diluted EPS (ttm)

    0.1100

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    410.51M

  • Total Debt/Equity (mrq)

    119.84%

  • Levered Free Cash Flow (ttm)

    1.22B

Research Analysis: RADLY

View More

Company Insights: RADLY

Research Reports: RADLY

View More

People Also Watch